Company Summary - Lombard Medical Technologies PLC (LSE:LMT)
1.10p
0.00p
FTSE AIM All Share Health Care Equipment & ServicesMarket cap: £9.254m
Review a company's summary page in more detail and see the key fundamentals at a glance. Sign-up to Premium now to make your investment decisions.
Sign-up to Premium's Free 7 Day trial See an improved company summary
Summary
Specialist cardiovascular device and polymer coatings company which focuses on discovering, developing and commercialising innovative products
| Financials - Interim (7/8/2009) | ||
|---|---|---|
| Turnover | £m | 1.25 |
| Pre-tax Profit | £m | -4.35 |
| EPS | p | -0.49 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| Simon Neathercoat | Chairman |
| John Rush | Chief Executive |
| Tim Hall | Finance Director |
Products Brands & Subsidiaries
Products & Brands
Aorfix; EndoRefix
Subsidiaries
PolyBioMed Ltd; Anson Medical Ltd; Lombard Medical Technologies Inc; LionMedical Ltd; Culzean Medical Devices Ltd
Broker Sentiment (1 brokers)
Strong SellStrong Buy
| Heading | Date |
|---|---|
| Disposal of Polymer Coatings Busi... | 17/11/2009 |
| Share Option Grant | 12/10/2009 |
| John B. Rush appointed CEO at Lo... | 12/10/2009 |
For more information
and investor relations, visit the
Lombard Medical Technologies PLC company website: